Keywords: USA, Biotech outlook 2010, Burrill, Financing, IPOs, Biosimilars, Partnering, M&A

Burrill's predictions on what lies ahead for US biotech in 2010

Article | 07 January 2010

As a prelude to the upcoming release of Biotech 2010-Life Sciences: Adapting for Success - the 24th edition of US ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in